| Jul 2 |
GRI Bio Announces Publication of Positive Preclinical Data from Lead Program GRI-0621 in the American Journal of Respiratory and Critical Care Medicine
|
| Jul 1 |
GRI Bio to Present at the 8th Annual IPF Summit
|
| Jun 28 |
GRI Bio Announces Closing of $4.0 Million Public Offering
|
| Jun 27 |
GRI Bio announces pricing of $4 million public offering
|
| Jun 27 |
GRI Bio Announces Korea Patent Granted for Proprietary Natural Killer T (NKT) Cell Modulators
|
| Jun 27 |
GRI Bio Announces Pricing of $4 Million Public Offering
|
| Jun 20 |
GRI Bio files to offer shares of common stock
|
| Jun 14 |
GRI Bio announces 1-for-13 reverse stock split
|
| Jun 12 |
Connect Biopharma Announces New Leadership and Chair of the Board of Directors
|
| Jun 11 |
GRI Bio (NASDAQ: GRI) to Present at the Virtual Investor Pitch Conference
|
